Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
DARE
$0.93
-32.12%
DARE · Dare Bioscience, Inc.
$0.93
-0.44 (-32.12%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current analysis of the conditions described above, there is substantial doubt about our ability to continue as a going concern within the 12-month period from the issuance date of the accompanying condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$14.22M
Shares
15.29M
All earnings calls
Earnings call · FY2024 Q4
Dare Bioscience, Inc. Q4 FY2024 Earnings Call
Dare Bioscience, Inc. Q4 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
-$63,647
-103.5% YoY
Net income · derived Q4
-$5.51M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 31, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 31, 2025 · complete as-filed document